Meet Isogenica at PEGS Europe in Lisbon From 11–13 November, Isogenica will be at PEGS Europe as a proud sponsor. Visit our stand to explore how our synthetic VHH antibody platforms accelerate reliable discovery. On Tuesday 11 November, Lurdes Rodrigues-Duarte,...
Connect with Isogenica at On Helix 2025 in Cambridge, July 3, 2025. Join Jessica Kaplunov, Ph.D Director of Business Development to connect and discuss science at ON Helix 2025: New Horizons for Bio Innovation, a one-day conference taking place on July 3rd at...
Connect with Isogenica at Antibody Engineering & Therapeutics Europe in Basel, June 10-12, 2025. Meet our team at Europe’s leading antibody event for discovery, engineering and therapeutic development in neurodegeneration, metabolism, and autoimmunity...
Connect with Isogenica at PEGS in Boston from May 12–16, 2025. Jessica Kaplunov, PhD, and Nicola Jane Evans, PhD will be on-site presenting, in poster format, new data on: CIS Display™ scalability and integration with NGS: How data-rich, high-throughput...
Connect with Isogenica at BIO-Europe Spring in Milan from March 17–19, 2025. Our team is eager to showcase how our VHH antibody technology is revolutionizing complex antibody drug discovery and driving forward the landscape of therapeutic solutions. If...
Join us for our next online webinar in collaboration with AXXAM. “Small modalities, deep impact”: VHH antibodies as complementary approaches for challenging therapeutic targets. In this webinar, Isogenica and Axxam will discuss their newly formed strategic...
